Schedule 13D ownership disclosure

MIRAGEN THERAPEUTICS, INC.

Security class unavailable · CUSIP: 60463E103

Event date: 2017-02-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-011148
Form type
SC 13D
Filer
Atlas Venture Fund VII L P
CIK
CIK 1346450
Filed
Feb 23, 2017
Reporting period
Feb 13, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub